The contribution of physics to Nuclear Medicine: physicians’ perspective on future directions

di Mankoff, David A, Pryma, Daniel A
Pubblicato in EJNMMI Phys (2014)

(68)Ga‐DOTATATE Positron Emission Tomography‐Computed Tomography Quantification Predicts Response to Somatostatin Analog Therapy in Gastroenteropancreatic Neuroendocrine Tumors

di Lee, Hwan, Eads, Jennifer R., Pryma, Daniel A.
Pubblicato in Oncologist (2020)

Development of Companion Diagnostics

di Mankoff, David A., Edmonds, Christine E., Farwell, Michael D., Pryma, Daniel A.
Pubblicato in Semin Nucl Med (2016)

Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: Crossing the blood-brain-barrier divide

di Chacko, Ann-Marie, Li, Chunsheng, Pryma, Daniel A., Brem, Steven, Coukos, George, Muzykantov, Vladimir R.
Pubblicazione 2013

Radiopharmaceutical Chemistry and Drug Development—What’s Changed?

di Kunos, Charles A., Mankoff, David A., Schultz, Michael K., Graves, Stephen A., Pryma, Daniel A.
Pubblicato in Semin Radiat Oncol (2021)

PARP-1 Expression Quantified by [(18)F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy

di Sander Effron, Samuel, Makvandi, Mehran, Lin, Lilie, Xu, Kuiying, Li, Shihong, Lee, Hsiaoju, Hou, Catherine, Pryma, Daniel A., Koch, Cameron, Mach, Robert H.
Pubblicato in Cancer Biother Radiopharm (2017)

The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes

di Guerraty, Marie A., Rao, H. Shanker, Anjan, Venkatesh Y., Szapary, Hannah, Mankoff, David A., Pryma, Daniel A., Rader, Daniel J., Dubroff, Jacob G.
Pubblicato in PLoS One (2020)

PARP-1–Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma

di Lee, Hwan, Riad, Aladdin, Martorano, Paul, Mansfield, Adam, Samanta, Minu, Batra, Vandana, Mach, Robert H., Maris, John M., Pryma, Daniel A., Makvandi, Mehran
Pubblicato in J Nucl Med (2020)

In vivo visualization of PARP inhibitor pharmacodynamics

di McDonald, Elizabeth S., Pantel, Austin R., Shah, Payal D., Farwell, Michael D., Clark, Amy S., Doot, Robert K., Pryma, Daniel A., Carlin, Sean D.
Pubblicato in JCI Insight (2021)

Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL):...

di Jimenez, Camilo, Chin, Bennett B, Noto, Richard A, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, DiPippo, Vincent A, Stambler, Nancy, Pryma, Daniel A
Pubblicato in J Endocr Soc (2021)

OR25-07 A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paragangliom...

di Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph Stephen, Solnes, Lilja B, DiPippo, Vincent A, Stambler, Nancy, Wong, Vivien, Pryma, Daniel A
Pubblicato in J Endocr Soc (2020)

The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer

di Makvandi, Mehran, Tilahun, Estifanos D., Lieberman, Brian P., Anderson, Redmond-Craig, Zeng, Chenbo, Xu, Kuiying, Hou, Catherine, McDonald, Elizabeth S., Pryma, Daniel A., Mach, Robert H.
Pubblicato in Biochem Biophys Res Commun (2015)

Endocrine Surgical Procedures During COVID-19: Patient Prioritization and Time to Surgery

di Ermer, Jae P., Ballester, Jacqueline M. Soegaard, Go, Beatrice C., Philipson, Benjamin, Gabriel, Peter E., Pryma, Daniel A., Fraker, Douglas L., Kelz, Rachel R., Wachtel, Heather
Pubblicato in J Surg Res (2021)

PennPET Explorer: Human Imaging on a Whole-Body Imager

di Pantel, Austin R., Viswanath, Varsha, Daube-Witherspoon, Margaret E., Dubroff, Jacob G., Muehllehner, Gerd, Parma, Michael J., Pryma, Daniel A., Schubert, Erin K., Mankoff, David A., Karp, Joel S.
Pubblicato in J Nucl Med (2020)

A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy

di Makvandi, Mehran, Xu, Kuiying, Lieberman, Brian P., Anderson, Redmond-Craig, Effron, Samuel Sander, Winters, Harrison D., Zeng, Chenbo, McDonald, Elizabeth S., Pryma, Daniel A., Greenberg, Roger A., Mach, Robert H.
Pubblicato in Cancer Res (2016)

Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chem...

di Luna, José Marcio, Chao, Hann-Hsiang, Shinohara, Russel T., Ungar, Lyle H., Cengel, Keith A., Pryma, Daniel A., Chinniah, Chidambaram, Berman, Abigail T., Katz, Sharyn I., Kontos, Despina, Simone, Charles B., Diffenderfer, Eric S.
Pubblicato in Clin Transl Radiat Oncol (2020)

PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma

di Dabagian, Hannah, Taghvaee, Tahereh, Martorano, Paul, Martinez, Daniel, Samanta, Minu, Watkins, Carolyn M., Chai, Richard, Mansfield, Adam, Graham, Thomas J., Maris, John M., Pryma, Daniel A., Mach, Robert H., Makvandi, Mehran
Pubblicato in ACS Pharmacol Transl Sci (2021)

Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

di Kipnis, Sarit T., Hung, Matthew, Kumar, Shria, Heckert, Jason M., Lee, Hwan, Bennett, Bonita, Soulen, Michael C., Pryma, Daniel A., Mankoff, David A., Metz, David C., Eads, Jennifer R., Katona, Bryson W.
Pubblicato in JAMA Netw Open (2021)

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity

di Gerhart-Hines, Zachary, Feng, Dan, Emmett, Matthew J., Everett, Logan J., Loro, Emanuele, Briggs, Erika R., Bugge, Anne, Hou, Catherine, Ferrara, Christine, Seale, Patrick, Pryma, Daniel A., Khurana, Tejvir S., Lazar, Mitchell A.
Pubblicazione 2013

Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer

di Li, Chunsheng, Wang, Junying, Hu, Jia, Feng, Yi, Hasegawa, Kosei, Peng, Xiaohui, Duan, Xingmei, Zhao, Aizhi, Mikitsh, John L., Muzykantov, Vladimir R., Chacko, Ann-Marie, Pryma, Daniel A., Dunn, Steven M., Coukos, George
Pubblicazione 2014